Hi all,
can somebody explain if the sales of an intermediate from company A to company B, who subsequently makes a product and by that modifies the characteristics of the intermediate, so they can not be deduced from final product destroy novelty of a later patent application (by party C) specificaly for said intermediate?
What is the situation of A had a generic patent covering that intermediate and B was an exclusive licensee under that patent - and that only sales of intermediate were from A to B and to no other party?
Is there any difference between US and European interpetation?
Thanks
can somebody explain if the sales of an intermediate from company A to company B, who subsequently makes a product and by that modifies the characteristics of the intermediate, so they can not be deduced from final product destroy novelty of a later patent application (by party C) specificaly for said intermediate?
What is the situation of A had a generic patent covering that intermediate and B was an exclusive licensee under that patent - and that only sales of intermediate were from A to B and to no other party?
Is there any difference between US and European interpetation?
Thanks